Abstract A prospective series of 20 patients with moderate to severe intraventricular haemorrhage (IVH) was studied for the effect of intraventricular administration of recombinant tissue plasminogen activator (rt-PA) on reduction of haematoma volume and prognosis. On the day of haemorrhage ventriculostomy was performed and 2 to 5 mg of rt-PA were injected via the external ventricular drainage, followed by drainage closure for two hours. In 14 patients rt-PA treatment was repeated. Computed tomography showed complete clot lysis or substantial reduction of intraventricular haematoma volume in 19 patients within 96 hours; the clearance of the third and fourth ventricle preceded the clearance of the lateral ventricles. Decrease of ventricular enlargement was seen in all but one patient with initial ventricular dilatation. Increase of haematoma volume and ventricular size was found in one patient. Outcome was minor or no neurological deficit in nine patients, disabling neurological deficit in six patients, and vegetative status in four patients. One patient did not survive the IVH. Intraventricular treatment with rt-PA seems effective in rapid lysis of intraventricular haematoma and normalisation of impaired CSF circulation. This treatment may contribute to an improvement in prognosis of moderate to severe IVH.
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Accompanying intraventricular haemorrhage (IVH) aggravates the prognosis of intracerebral and aneurysmal haemorrhage. [1] [2] [3] [4] Haemorrhage extending into all ventricular chambers results in mortalities ranging between 60% and 91%. plasminogen activator (rt-PA) given intraventricularly achieve reduction of intraventricular haematoma within a few days.11-'3 The present study was undertaken to evaluate how the outcome could be influenced by accelerated intraventricular haematoma resolution and to assess the efficacy and safety of intraventricular fibrinolytic treatment with rt-PA.
Materials and methods

PATIENT POPULATION
Twenty patients with moderate to severe IVH diagnosed by CT were studied. There were 10 women and 10 men (age range 25 to 78 (mean 54)). In eight patients, IVH was due to rupture of an angiographically verified aneurysm of the anterior communicating or internal carotid artery. In nine patients, IVH was the result of penetration of intracerebral haematoma into the ventricles. The spontaneous brain haemorrhage was associated with hypertension in five patients and with arteriovenous malformation in four patients. In two cases the aetiology of the bleeding remained unknown despite angiography and MRI (table 1) .
In 14 patients the IVH extended into all ventricles, in five patients the haematoma filled the third and fourth ventricle and a single lateral ventricle. In one patient the blood was distributed in both lateral ventricles and in the third ventricle. The grading system proposed by Graeb et al was used to assess the severity of the IVH (table 2).6 According to the grading system, nine patients presented with moderate IVH (score 5-8) and 11 patients with severe IVH (score 9-12) (table 1). The ventriculocranial ratio (ratio of the width of the ventricles between the caudate nuclei to the width of the brain at the same level) was calculated for evaluation of the ventricular size. The ratio of 0-155 was considered to be the upper limit of the normal. 14 All but two patients presented with ventricular dilatation (mean 0.23).
All patients were admitted with impaired consciousness and nine were comatose. The Glasgow coma scale (GCS) score ranged from 3 to 14 (mean GCS = Glasgow coma score'5; GOS = Glasgow outcome score. '6 was placed through a frontal twist drill hole immediately after diagnosis of the IVH. The correct intraventricular positioning of the ventriculostomy needle was confirmed in all but one case by CT before rt-PA infusion. Two to 5 mg of rt-PA were slowly injected via the ventriculostomy needle, followed by two hours of drainage closure. After reopening the ventricular drainage, the CSF was drained without a pressure gradient. Computed tomography was performed 16 to 24 hours after injection of rt-PA. The fibrinolytic treatment was continued until appreciable reduction of the haematoma volume in the lateral ventricles and clearance of the third and fourth ventricles were confirmed; in seven patients the rt-PA injections were repeated once, in six patients three injections of rt-PA were required. One patient received four injections of rt-PA. In patients with intraventricular haematoma due to ruptured aneurysm, haematoma lysis was initiated after clipping the aneurysm. In patients with IVH due to arteriovenous malformation, fibrinolytic treatment preceded excision of the angioma. In all patients the rt-PA treatment was started 12 to 48 hours after onset of the symptoms. Coagulation profiles were obtained before and after rt-PA treatment to rule out any systemic coagulopathy. 
Results
Complete removal or substantial reduction of haematoma size in the lateral ventricles was achieved in 19 of 20 patients within one to three days (mean 1-8 days). In the cases of incomplete clearance, the remaining blood did not exert local mass effect. In 19 of 20 patients the blood clots in the third and fourth ventricles were completely lysed in one to two days (mean 1 2 days) after initiation of the intraventricular rt-PA treatment ( figure) . In all cases the size of the accompanying intracerebral haematoma remained unchanged. Decrease of ventricular enlargement was seen in all but one patient with initial ventricular dilatation. The ventriculocranial ratio improved from a mean of 0-23 (pretreatment) to 0-17 (post-treatment) ( 
COMPLICATIONS
In one patient with IVH and hypertensive brain haemorrhage the volume of the intraventricular haematoma increased after initiation of the rt-PA treatment. Because of a deviation from the treatment protocol, uneventful bilateral ventriculostomy was not confirmed by CT in this patient before intraventricular rt-PA injection. It remained unclear whether complication of ventriculostomy or an rt-PA induced rebleed caused haematoma enlargement. In our series as well as in the clinical studies of intracisternal and intraventricular application of rt-PA, systemic fibrinolysis or coagulopathy were not found. 12 24 26 Mayfrank et al reported one fatal meningitis related to treatment with intraventricular rt-PA.12
In our series and in the series of Mayfrank et al the volume of accompanying intracerebral haematoma remained unchanged during rt-PA treatment.'2 In the clinical studies of intracisternal application of rt-PA for the prevention of cerebral vasospasm after aneurysmal subarachnoid haemorrhage, epidural haematoma and increase in subarachnoid blood were noted but no intracerebral bleeding complication was found.2629 These findings suggest that the fibrinolytic effect of rt-PA given intraventricularly is predominantly limited to the CSF pathways. Therefore, we believe that definitive haemostasis before the use of intraventricular rt-PA is not necessary in patients with an intracerebral source of bleeding.
PROGNOSIS
Our results suggest that efficacious haematoma lysis improves the poor prognosis of moderate to 
